Abdel Abdel-Rahman | Cardiovascular Pharmacology | Innovative Research Award

Innovative Research Award

Abdel Abdel-Rahman
East Carolina University, United States
Abdel Abdel-Rahman
Affiliation East Carolina University
Country United States
Scopus ID 7102847207
Documents 181
Citations 3711
h-index 33
Subject Area Cardiovascular Pharmacology
Event International Popular Scientist Awards
ORCID
0000-0002-3461-2190

Abdel Abdel-RahmanΒ  the Innovative Research Award recognizes distinguished scientific contributions in the field of cardiovascular pharmacology and related biomedical sciences. Abdel Abdel-Rahman of East Carolina University has developed an extensive scholarly portfolio that reflects sustained academic productivity, interdisciplinary collaboration, and measurable scientific impact in cardiovascular research and pharmacological sciences.[1] His publication record, citation performance, and recognized expertise in cardiovascular pharmacology position him as a notable contributor within the international scientific community.[2]

Abstract

Abdel Abdel-Rahman has contributed extensively to cardiovascular pharmacology through scholarly investigations addressing vascular physiology, autonomic regulation, pharmacodynamics, and therapeutic mechanisms associated with cardiovascular disorders. His academic output demonstrates a strong emphasis on translational biomedical research and pharmacological innovation.[1] With 181 indexed documents, 3711 citations, and an h-index of 33, his work has achieved significant scholarly visibility and international academic engagement.[2] The Innovative Research Award acknowledges these contributions within the framework of the International Popular Scientist Awards program.

Keywords

The Innovative Research Award in Cardiovascular Pharmacology recognizes pioneering contributions that advance the understanding and treatment of cardiovascular diseases through pharmacological innovation and biomedical discovery. This award celebrates researchers whose work bridges Pharmacological Research, Biomedical Sciences, and Translational Medicine to develop safer, more effective cardiovascular therapeutics. It honors excellence in innovative drug development, clinical applications, and transformative scientific research that improves global cardiovascular health outcomes.

Introduction

Cardiovascular pharmacology remains an essential scientific discipline within biomedical research due to its role in understanding cardiovascular diseases, therapeutic mechanisms, and pharmacological interventions. Research within this domain contributes to the development of treatment strategies for hypertension, vascular dysfunction, and cardiac pathophysiology.[2]

Abdel Abdel-Rahman has maintained a sustained academic presence in this field through research activities associated with East Carolina University. His work demonstrates consistent scholarly productivity and scientific engagement within cardiovascular and pharmacological sciences.[1] The International Popular Scientist Awards recognize researchers whose scientific achievements contribute meaningfully to academic advancement and interdisciplinary biomedical knowledge.

Research Profile

The research profile of Abdel Abdel-Rahman reflects extensive engagement in cardiovascular pharmacology, autonomic regulation, neuropharmacology, and vascular function research. His scientific investigations have addressed mechanisms influencing blood pressure regulation, pharmacological responses, and cardiovascular signaling pathways.[2]

Bibliometric indicators associated with his scholarly output demonstrate sustained academic visibility. According to indexed scholarly databases, his work has accumulated thousands of citations and a notable h-index, indicating both productivity and citation influence within the biomedical research community.[2]

Research Contributions

Abdel Abdel-Rahman’s scientific contributions include investigations into cardiovascular regulation, pharmacological interactions, and neurovascular signaling. His studies have explored physiological mechanisms underlying vascular control and the pharmacodynamics associated with cardiovascular therapeutics.[5]

Several publications associated with his research profile have examined experimental pharmacological models relevant to cardiovascular disease mechanisms and therapeutic responses. These contributions have enhanced understanding of autonomic modulation and vascular pharmacology within preclinical and translational research contexts.[1]

Publications

The publication portfolio of Abdel Abdel-Rahman includes peer-reviewed articles focusing on cardiovascular pharmacology and related biomedical sciences. His indexed research output demonstrates continuity in scientific productivity and interdisciplinary collaboration.[1]

Representative publications indexed within international scholarly databases have contributed to citation growth and broader academic dissemination.[2]

Research Impact

The scientific impact of Abdel Abdel-Rahman’s work is reflected through citation metrics, publication visibility, and continued relevance within cardiovascular pharmacology research. His research output has contributed to ongoing academic discussions concerning cardiovascular physiology, vascular pharmacology, and therapeutic intervention strategies.

An h-index of 33 indicates consistent citation performance across multiple scholarly works, while a citation count exceeding 3700 demonstrates sustained engagement by the international biomedical research community.[2] These indicators collectively support the scholarly significance of his research activities.

Award Suitability

The Innovative Research Award recognizes individuals demonstrating substantial scientific contributions, scholarly influence, and research advancement within their respective disciplines. Abdel Abdel-Rahman’s academic profile aligns with these criteria through sustained publication activity, recognized citation impact, and research contributions within cardiovascular pharmacology.[1]

His scientific work reflects methodological rigor, interdisciplinary relevance, and ongoing contributions to pharmacological sciences. Participation in the International Popular Scientist Awards further highlights the importance of promoting impactful biomedical research and academic excellence.[1]

Conclusion

Abdel Abdel-Rahman’s scholarly record demonstrates a sustained commitment to cardiovascular pharmacology and biomedical research. Through extensive publication activity, measurable citation influence, and interdisciplinary scientific contributions, he has established a recognized academic presence within the international research community.[2] The Innovative Research Award acknowledges these accomplishments within the broader context of scientific advancement and research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Abdel Abdel-Rahman, Author ID 7102847207. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102847207
  2. ORCID. (n.d.). ORCID profile for Abdel Abdel-Rahman.
    https://orcid.org/0000-0002-3461-2190
  3. International Popular Scientist Awards. (n.d.). Research recognition and scientific excellence initiatives.
    https://popularscientist.com/
  4. Katzung, B. G. (2021). Basic and Clinical Pharmacology. McGraw-Hill Education

Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Dr. Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Professor First Hospital of Jilin University China

Professor Jiancheng Xu (MD, PhD) is a distinguished clinical microbiologist with over 20 years of experience in laboratory medicine. He currently serves as Professor, Doctoral Supervisor, and Deputy Director of the Department of Laboratory Medicine at the First Hospital of Jilin University, China. A joint-training PhD scholar from the University of Louisville, USA, he has made significant contributions to microbiology, diabetic complications, and laboratory diagnostics. He is also a reviewer for several international journals and an influential figure in multiple national medical associations. Outside the lab, he enjoys running and badminton. πŸƒβ€β™‚οΈπŸΈ

Profile

Orcid

πŸŽ“ Education

Professor Xu’s academic path reflects a commitment to excellence. He earned his MD from Norman Bethune University of Medical Sciences (1995–2000), followed by an MS in Laboratory Medicine and a PhD in Internal Medicine from Jilin University (2002–2010). He undertook a joint PhD program at the University of Louisville (2008–2009), enhancing his global research exposure. He further completed a postdoctoral fellowship in Laboratory Medicine at China Medical University (2012–2016), solidifying his scientific and clinical foundation. πŸŽ“πŸ§ͺ

πŸ’Ό Professional Experience

Professor Xu has advanced steadily through academic and clinical ranks. Beginning as a Research Assistant (2000–2006), he became an Attending Physician (2006–2010), Associate Professor (2010–2014), and finally Professor in 2014 at the First Hospital of Jilin University. He currently serves as the Deputy Director of the Department of Laboratory Medicine, mentoring numerous doctoral candidates and leading transformative research. πŸ§‘β€πŸ«πŸ₯

πŸ”¬ Research Interests

Professor Xu’s research spans across vital domains:

  1. 🧠 Mechanism of Diabetic Complications

  2. 🦠 Bacterial Resistance Mechanisms and Surveillance

  3. πŸ“Š Establishment of Reference Intervals for Clinical Tests

  4. πŸ€– Disease Prediction Modeling with Machine Learning

  5. 🧬 Trace Element Metabolism in Diabetic Models

His work integrates clinical insights with computational analytics to develop predictive tools and diagnostic advancements in laboratory medicine.

πŸ† Awards & Honors

Professor Xu’s outstanding contributions have earned him numerous accolades and appointments:

  • πŸ… Chairman, Society of Laboratory Medicine, Jilin Medical Security Association

  • πŸ… Vice Chairman, Youth Committee, Chinese Society of Laboratory Medicine

  • πŸ… Vice Chairman, Youth Committee, Jilin Medical Association

  • πŸ… Member, Standing Committees across multiple national and provincial laboratory medicine societies

  • πŸ“š Editorial Board Member, Chinese Journal of Laboratory Medicine

  • πŸ§ͺ Reviewer for Biological Trace Element Research, OMICS, and others

He has successfully led over 33 funded research projects, totaling Β₯7.04 million RMB.

πŸ“š Publications Top Notes:Β 

Professor Xu has authored over 125 peer-reviewed articles, with an H-index of 16 and over 1269 citations. His top publications as a corresponding author include:

🧬 A Prognostic Model to Predict Recovery of COVID-19 Patients Based on Longitudinal Laboratory Findings
Virologica Sinica, 2020 – Cited by 39 articles

🧫 The Function of T Follicular Helper Cells in the Autoimmune Liver Diseases
Journal of Immunology Research, 2020 – Cited by 27 articles

πŸ§ͺ Negative Results in Nucleic Acid Test of COVID-19 Patients: Assessment from Clinical Laboratories
Annals of Palliative Medicine, 2020 – Cited by 18 articles

βš–οΈ Age- and Sex-Specific Pediatric Reference Intervals of Serum Electrolytes
American Journal of Clinical Pathology, 2020 – Cited by 21 articles

🧫 Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2
Health Security, 2020 – Cited by 14 articles

❀️ Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in COVID-19
BioMed Research International, 2020 – Cited by 33 articles

Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation